An inconvenient hurdle in the practice of nanomedicine is the protein corona, a spontaneous
collection of biomolecular species by nanoparticles in living systems. The protein corona is …

Understanding the in vivo transport of nanoparticles provides guidelines for designing
nanomedicines with higher efficacy and fewer side effects. Among many factors, the size of …

How soft corona, the protein corona's outer layer, contributes to biological identity of
nanomaterials is largely because capturing protein composition of the soft corona in situ …

Increasing the yield of reactive oxygen species (ROS) to enhance oxidative stress in cells is
an eternal goal in cancer therapy. In this study, BiVO4 artificial nanozyme is developed with …

Amorphous calcium carbonate plays a key role as transient precursor in the early stages of
biogenic calcium carbonate formation in nature. However, due to its instability in aqueous …

SNIO–CBP, a single-nanometer iron oxide (SNIO) nanoparticle functionalized with a type I
collagen-binding peptide (CBP), was developed as a T 1-weighted MRI contrast agent with …

Nanomaterials are promising carriers to improve the bioavailability and therapeutic
efficiency of drugs by providing preferential drug accumulation at their sites of action, but …

With excellent physicochemical properties, inorganic nanomaterials (INMs) have exhibited a
series of attractive applications in biomedical fields. Biological barriers prevent successful …

Overall, 12% of the global population (800 million) suffers from liver disease, which causes 2
million deaths every year. Liver injury involving characteristic reactive oxygen/nitrogen …

Lipid-based polymeric nanoparticles are the highly popular carrier systems for cancer drug
therapy. But presently, detailed investigations have revealed their flaws as drug delivery …